{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-25-003756","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.345724+00:00","generated_at":"2026-05-16T21:49:14.651666+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Silexion Q3 net loss narrows to $3.3M; cash $9.2M; Phase 2/3 trial on track for H1 2026","bullets":["Net loss $3.3M ($2.88/share) vs $11.9M ($274.25) a year ago, aided by lower share-based compensation.","Cash and equivalents $9.2M as of Sep 30, up from $1.2M at Dec 2024, after raising ~$9.5M in Q3.","R&D spend $2.2M (-31% YoY); G&A $1.1M (-77% YoY); shareholders' equity improved to $7.0M.","Phase 2/3 trial of SIL204 in KRAS-driven cancers on track for H1 2026; regulatory submissions planned for Q4 2025/Q1 2026.","New preclinical data shows SIL204 efficacy across five cancer types, including first gastric cancer evidence."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-25-003756","json":"https://secwatch.observer/filing/0001178913-25-003756.json","markdown":"https://secwatch.observer/filing/0001178913-25-003756.md","text":"https://secwatch.observer/filing/0001178913-25-003756.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003756/0001178913-25-003756-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003756/zk2533972.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T21:49:14.651666+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}